Search

Louise Wang Zhiying Humphrey

Supervisory Patent Examiner (ID: 6195, Phone: (571)272-5543 , Office: P/1657 )

Most Active Art Unit
1648
Art Unit(s)
1648, 1657
Total Applications
627
Issued Applications
269
Pending Applications
52
Abandoned Applications
312

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1171857 [patent_doc_number] => 06750019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-15 [patent_title] => 'Antisense modulation of insulin-like growth factor binding protein 5 expression' [patent_app_type] => B2 [patent_app_number] => 09/975123 [patent_app_country] => US [patent_app_date] => 2001-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27925 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750019.pdf [firstpage_image] =>[orig_patent_app_number] => 09975123 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/975123
Antisense modulation of insulin-like growth factor binding protein 5 expression Oct 8, 2001 Issued
Array ( [id] => 6016927 [patent_doc_number] => 20020103154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs' [patent_app_type] => new [patent_app_number] => 09/965602 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 28962 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103154.pdf [firstpage_image] =>[orig_patent_app_number] => 09965602 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/965602
Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs Sep 26, 2001 Abandoned
Array ( [id] => 6340673 [patent_doc_number] => 20020034505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor' [patent_app_type] => new [patent_app_number] => 09/962489 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8350 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034505.pdf [firstpage_image] =>[orig_patent_app_number] => 09962489 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/962489
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor Sep 24, 2001 Issued
Array ( [id] => 6014986 [patent_doc_number] => 20020102255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies' [patent_app_type] => new [patent_app_number] => 09/682562 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4050 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102255.pdf [firstpage_image] =>[orig_patent_app_number] => 09682562 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/682562
CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies Sep 19, 2001 Issued
Array ( [id] => 6545157 [patent_doc_number] => 20020137711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Control of NK cell function and survival by modulation of SHIP activity' [patent_app_type] => new [patent_app_number] => 09/955174 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13466 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137711.pdf [firstpage_image] =>[orig_patent_app_number] => 09955174 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/955174
Control of NK cell function and survival by modulation of SHIP activity Sep 18, 2001 Abandoned
Array ( [id] => 6792511 [patent_doc_number] => 20030087855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Antisense modulation of protein kinase R expression' [patent_app_type] => new [patent_app_number] => 09/953611 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26179 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087855.pdf [firstpage_image] =>[orig_patent_app_number] => 09953611 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/953611
Antisense modulation of protein kinase R expression Sep 12, 2001 Abandoned
Array ( [id] => 6740108 [patent_doc_number] => 20030157477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Methods and reagents for identifying synthetic genetic elements' [patent_app_type] => new [patent_app_number] => 09/950983 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16996 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157477.pdf [firstpage_image] =>[orig_patent_app_number] => 09950983 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/950983
Methods and reagents for identifying synthetic genetic elements Sep 11, 2001 Abandoned
Array ( [id] => 6760835 [patent_doc_number] => 20030124196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Pulsatile release compositions and methods for enhanced intestinal drug absorption' [patent_app_type] => new [patent_app_number] => 09/944493 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20543 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124196.pdf [firstpage_image] =>[orig_patent_app_number] => 09944493 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/944493
Pulsatile release compositions and methods for enhanced intestinal drug absorption Aug 21, 2001 Abandoned
Array ( [id] => 424986 [patent_doc_number] => 07270968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'PTH analogs for renal osteodystrophy and related uses' [patent_app_type] => utility [patent_app_number] => 10/344744 [patent_app_country] => US [patent_app_date] => 2001-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11293 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/270/07270968.pdf [firstpage_image] =>[orig_patent_app_number] => 10344744 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/344744
PTH analogs for renal osteodystrophy and related uses Aug 13, 2001 Issued
Array ( [id] => 5873960 [patent_doc_number] => 20020048814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Methods of gene silencing using poly-dT sequences' [patent_app_type] => new [patent_app_number] => 09/929745 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8749 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048814.pdf [firstpage_image] =>[orig_patent_app_number] => 09929745 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/929745
Methods of gene silencing using poly-dT sequences Aug 12, 2001 Abandoned
Array ( [id] => 6064129 [patent_doc_number] => 20020032166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Biocompatible cationic detergents and uses therefor' [patent_app_type] => new [patent_app_number] => 09/924898 [patent_app_country] => US [patent_app_date] => 2001-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 18628 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032166.pdf [firstpage_image] =>[orig_patent_app_number] => 09924898 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/924898
Biocompatible cationic detergents and uses therefor Aug 6, 2001 Abandoned
Array ( [id] => 6801606 [patent_doc_number] => 20030096771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Antisense modulation of hormone-sensitive lipase expression' [patent_app_type] => new [patent_app_number] => 09/915814 [patent_app_country] => US [patent_app_date] => 2001-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29126 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096771.pdf [firstpage_image] =>[orig_patent_app_number] => 09915814 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/915814
Antisense modulation of hormone-sensitive lipase expression Jul 25, 2001 Abandoned
Array ( [id] => 6870589 [patent_doc_number] => 20030083279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Antisense modulation of glioma-associated oncogene-3 expression' [patent_app_type] => new [patent_app_number] => 09/910185 [patent_app_country] => US [patent_app_date] => 2001-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25106 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083279.pdf [firstpage_image] =>[orig_patent_app_number] => 09910185 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/910185
Antisense modulation of glioma-associated oncogene-3 expression Jul 17, 2001 Abandoned
Array ( [id] => 5873460 [patent_doc_number] => 20020048581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Modulation of nitric oxide synthase by PKC' [patent_app_type] => new [patent_app_number] => 09/907012 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15070 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048581.pdf [firstpage_image] =>[orig_patent_app_number] => 09907012 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/907012
Modulation of nitric oxide synthase by PKC Jul 16, 2001 Abandoned
Array ( [id] => 925602 [patent_doc_number] => 07316900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-08 [patent_title] => 'Methylated nucleotide regulation of gene expression' [patent_app_type] => utility [patent_app_number] => 10/332542 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4723 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/316/07316900.pdf [firstpage_image] =>[orig_patent_app_number] => 10332542 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/332542
Methylated nucleotide regulation of gene expression Jul 12, 2001 Issued
Array ( [id] => 535173 [patent_doc_number] => 07173014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'HIV-specific synthetic oligonucleotides and methods of their use' [patent_app_type] => utility [patent_app_number] => 09/896692 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11145 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173014.pdf [firstpage_image] =>[orig_patent_app_number] => 09896692 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/896692
HIV-specific synthetic oligonucleotides and methods of their use Jun 28, 2001 Issued
Array ( [id] => 5936085 [patent_doc_number] => 20020061585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Ribozymal nucleic acid' [patent_app_type] => new [patent_app_number] => 09/880821 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8427 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061585.pdf [firstpage_image] =>[orig_patent_app_number] => 09880821 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/880821
Ribozymal nucleic acid Jun 14, 2001 Issued
Array ( [id] => 1248085 [patent_doc_number] => 06673611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Nucleic acid molecules with novel chemical compositions capable of modulating gene expression' [patent_app_type] => B2 [patent_app_number] => 09/866316 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21716 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673611.pdf [firstpage_image] =>[orig_patent_app_number] => 09866316 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/866316
Nucleic acid molecules with novel chemical compositions capable of modulating gene expression May 24, 2001 Issued
Array ( [id] => 1043606 [patent_doc_number] => 06867039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-15 [patent_title] => 'Antisense modulation of dual specific phosphatase 5 expression' [patent_app_type] => utility [patent_app_number] => 09/865993 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25053 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867039.pdf [firstpage_image] =>[orig_patent_app_number] => 09865993 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/865993
Antisense modulation of dual specific phosphatase 5 expression May 24, 2001 Issued
Array ( [id] => 6750966 [patent_doc_number] => 20030045487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Antisense modulation of phospholipase A2, group llA (synovial) expression' [patent_app_type] => new [patent_app_number] => 09/865866 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26804 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045487.pdf [firstpage_image] =>[orig_patent_app_number] => 09865866 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/865866
Antisense modulation of phospholipase A2, group llA (synovial) expression May 24, 2001 Abandoned
Menu